drugset
drugset / Trial / NCT01246193

CKD-828(80/2.5mg) Pharmacokinetic Study

NCT01246193 ↗

Phase 1 Completed 65 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics of CKD-828(Fixed Dose Combination Tablet; Telmisartan and S-Amlodipine) in healthy volunteer.

Timeline

Start
2010-11
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject S-amlodipine Unknown 2.5 mg Oral
Subject Telmisartan Other / unclassified 80 mg Oral

Indications

hypertensive disorder